Population pharmacokinetics, safety and dosing optimization of voriconazole in patients with liver dysfunction: A prospective observational studyDan Tang, Daxiong Xiang, Yi Tian et al.|British Journal of Clinical Pharmacology|2020Cited by 54
Enhancing voriconazole therapy in liver dysfunction: exploring administration schemes and predictive factors for trough concentration and efficacyYi‐Chang Zhao, Miao Yan, Huaiyuan Liu et al.|Frontiers in Pharmacology|2024Cited by 7
Predictors of Voriconazole Trough Concentrations in Patients with Child–Pugh Class C Cirrhosis: A Prospective StudyYi‐Chang Zhao, Miao Yan, Jingjing Hou et al.|Antibiotics|2021Cited by 4
Voriconazole Adjustment for Liver Dysfunction (VALID): From Population Pharmacokinetic Model to the Real-WorldHuaiyuan Liu, Miao Yan, Yi‐Chang Zhao et al.|Research Square|2025Cited by 0
Higher Depressive Symptom Burden is Associated with Elevated Liver Disease Risk: Longitudinal Evidence from Two National Aging CohortsYi‐Chang Zhao, Miao Yan, Shiqi Wu et al.|SSRN Electronic Journal|2025Cited by 0